SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-021086
Filing Date
2019-08-06
Accepted
2019-08-06 11:20:08
Documents
1
Period of Report
2019-07-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2143
  Complete submission text file 0000899243-19-021086.txt   3864
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Issuer) CIK: 0001117480 (see all company filings)

IRS No.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1792 BELL TOWER LANE SUITE 222 WESTON FL 33326
Business Address 1792 BELL TOWER LANE SUITE 222 WESTON FL 33326 954-315-3660
CANTEX PHARMACEUTICALS, INC. (Reporting) CIK: 0001374961 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35867 | Film No.: 191000888
SIC: 2834 Pharmaceutical Preparations